Will a hantavirus outbreak offset the regulatory risks weighing on Moderna stock? The path to recovery is far from certain.

Moderna stock climbed after the deadly hantavirus outbreak drew investors' attention to the company's ongoing infectious ...

CAMBRIDGE, MA / ACCESS Newswire / May 12, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked no. 1 on ...

The company confirmed early-stage hantavirus research as a WHO-confirmed outbreak grows, while flu vaccine data published in ...

Shares of Moderna ( MRNA) were up nearly 7% in recent trading, following a 12% jump Friday, after Bloomberg reported the ...

Inovio Pharmaceuticals and Novavax stocks pare back earlier gains as the rally loses enthusiasm.

March 4 (Reuters) - Moderna shares rose ⁠9% ⁠on Wednesday after it settled ⁠a long-running legal battle over the technology that made its COVID-19 vaccine possible, removing an overhang and allowing ...

(Reuters) -Moderna posted a smaller-than-expected quarterly loss and reduced its annual operating expenses outlook by $700 million on Thursday, helped by lower production costs and a cutback in ...

The hantavirus outbreak on the MV Hondius poses an ‘extremely low’ overall risk to the public, health officials said ...

Salesforce Inc. (NYSE:CRM) is one of the cheap stocks to buy for the next 10 years. On April 28, Salesforce and Moderna ...

An mRNA-based flu shot could make a huge difference in flu prevention, allowing scientists to pick a better strain match.

Marjorie Taylor Greene and other conservative commentators have claimed that Moderna is developing a hantavirus mRNA vaccine.